Free Trial

Sharecare (SHCR) Competitors

$0.84
-0.02 (-2.33%)
(As of 06/7/2024 ET)

SHCR vs. MYPS, LVOX, LTCH, PTNRY, WGS, PNTG, INNV, TALK, DCGO, and PIII

Should you be buying Sharecare stock or one of its competitors? The main competitors of Sharecare include PLAYSTUDIOS (MYPS), LiveVox (LVOX), Latch (LTCH), Partner Communications (PTNRY), GeneDx (WGS), The Pennant Group (PNTG), InnovAge (INNV), Talkspace (TALK), DocGo (DCGO), and P3 Health Partners (PIII).

Sharecare vs.

Sharecare (NASDAQ:SHCR) and PLAYSTUDIOS (NASDAQ:MYPS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, community ranking, earnings, analyst recommendations and valuation.

Sharecare has a beta of 0.33, indicating that its stock price is 67% less volatile than the S&P 500. Comparatively, PLAYSTUDIOS has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500.

In the previous week, Sharecare had 13 more articles in the media than PLAYSTUDIOS. MarketBeat recorded 14 mentions for Sharecare and 1 mentions for PLAYSTUDIOS. Sharecare's average media sentiment score of 0.00 equaled PLAYSTUDIOS'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sharecare
0 Very Positive mention(s)
0 Positive mention(s)
14 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PLAYSTUDIOS
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

PLAYSTUDIOS has a net margin of -5.64% compared to Sharecare's net margin of -30.71%. PLAYSTUDIOS's return on equity of -6.73% beat Sharecare's return on equity.

Company Net Margins Return on Equity Return on Assets
Sharecare-30.71% -19.78% -14.04%
PLAYSTUDIOS -5.64%-6.73%-5.59%

PLAYSTUDIOS received 5 more outperform votes than Sharecare when rated by MarketBeat users. However, 38.89% of users gave Sharecare an outperform vote while only 38.71% of users gave PLAYSTUDIOS an outperform vote.

CompanyUnderperformOutperform
SharecareOutperform Votes
7
38.89%
Underperform Votes
11
61.11%
PLAYSTUDIOSOutperform Votes
12
38.71%
Underperform Votes
19
61.29%

35.1% of Sharecare shares are owned by institutional investors. Comparatively, 37.5% of PLAYSTUDIOS shares are owned by institutional investors. 29.3% of Sharecare shares are owned by insiders. Comparatively, 14.3% of PLAYSTUDIOS shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

PLAYSTUDIOS has lower revenue, but higher earnings than Sharecare. PLAYSTUDIOS is trading at a lower price-to-earnings ratio than Sharecare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sharecare$445.25M0.68-$128.50M-$0.37-2.26
PLAYSTUDIOS$310.89M0.97-$19.39M-$0.13-17.23

Sharecare presently has a consensus price target of $1.50, suggesting a potential upside of 79.02%. PLAYSTUDIOS has a consensus price target of $4.50, suggesting a potential upside of 100.89%. Given PLAYSTUDIOS's stronger consensus rating and higher probable upside, analysts clearly believe PLAYSTUDIOS is more favorable than Sharecare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sharecare
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
PLAYSTUDIOS
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

PLAYSTUDIOS beats Sharecare on 12 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHCR vs. The Competition

MetricSharecareHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$303.66M$828.94M$5.33B$8.17B
Dividend YieldN/A1.79%2.73%4.04%
P/E Ratio-2.2633.12167.3218.17
Price / Sales0.683.172,423.0777.69
Price / CashN/A19.2835.2130.80
Price / Book0.692.384.974.33
Net Income-$128.50M-$14.18M$110.34M$216.21M
7 Day Performance2.90%3.90%-1.05%-1.43%
1 Month Performance21.28%6.48%-0.61%-0.59%
1 Year Performance-48.60%18.56%2.92%3.58%

Sharecare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MYPS
PLAYSTUDIOS
2.473 of 5 stars
$2.32
+4.5%
$4.50
+94.0%
-51.2%$312.75M$308.59M-17.84697News Coverage
Gap Down
LVOX
LiveVox
0 of 5 stars
$3.73
+0.8%
$4.50
+20.6%
+29.1%$353.01M$136.02M-14.35627High Trading Volume
LTCH
Latch
0 of 5 stars
$0.50
flat
N/A-64.7%$71.81M$41.36M0.00440Gap Down
PTNRY
Partner Communications
0 of 5 stars
$3.80
-2.8%
N/A-4.7%$704.67M$1.08B10.562,637
WGS
GeneDx
0.6911 of 5 stars
$27.28
+13.2%
$18.75
-31.3%
+252.3%$712.61M$221.85M-5.271,000Insider Buying
News Coverage
Positive News
PNTG
The Pennant Group
2.4113 of 5 stars
$23.82
+2.5%
$24.00
+0.8%
+69.0%$697.96M$544.89M44.115,791Positive News
INNV
InnovAge
0.5732 of 5 stars
$4.84
+4.8%
$6.50
+34.3%
N/A$628.26M$688.09M-20.172,100
TALK
Talkspace
0.8227 of 5 stars
$2.66
+3.1%
$3.00
+12.8%
+148.1%$437.79M$150.04M-33.25472
DCGO
DocGo
2.6723 of 5 stars
$3.03
+5.6%
$7.75
+155.8%
-66.8%$291.49M$624.29M15.154,164
PIII
P3 Health Partners
1.0241 of 5 stars
$0.58
+11.5%
$4.75
+716.3%
-88.8%$164.38M$1.27B-0.99400Gap Up

Related Companies and Tools

This page (NASDAQ:SHCR) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners